Why markets already priced in a vaccine approval, stellar gains from AIM stocks in 2020, retail’s latest challenge and dealing with NS&I’s punishing rate cuts
The UK’s status as the first country in the world to approve Pfizer’s Covid vaccine failed to move stock markets on the day of the news. Listen to the podcast to find out why markets reacted in this way.
Tom Sieber from Shares magazine joins the show to discuss the reasons why the AIM market has done nearly as well as the US S&P 500 in 2020 and significantly outperformed large cap UK stocks in the FTSE 100.
The podcast looks at the large rate cuts on NS&I accounts and what savers can do to improve their situation. And the team also debate the latest in the retail sector after Debenham’s struggles and Arcadia going into administration.
Presented by AJ Bell’s Dan Coatsworth and Laith Khalaf
Latest podcasts:
Tesla, Netflix, Premium Bonds, gold prices and tariff turmoil continues
In this week’s AJ Bell Money and Markets podcast, Charlene Young and Laura Suter break down the latest headlines affecting your finances and investments. ... Read more
Money & Markets Podcast | Thu, 24/04/2025 - 17:12
Tariff turmoil, Tesco warns of price wars and an update on AJ Bell funds
On this week’s episode of the AJ Bell Money and Markets Danni Hewson and Tom Sieber from Shares magazine dig into what has been another ridiculously busy... Read more
Money & Markets Podcast | Thu, 17/04/2025 - 16:28
What kids really think about money (and what we’re teaching them!)
In this episode of the AJ Bell Money Matters podcast, Danni and Laura hear from the team's children spanning from four to eighteen. We know money habits... Read more
Money Matters Podcast | Wed, 16/04/2025 - 08:33